EFFECT OF FUROSEMIDE AND TORASEMIDE ON HEART RATE VARIABILITY AND VENTRICULAR RHYTHM DISORDERS IN PATIENTS WITH CHRONIC HEART FAILURE COMPLICATING ISCHEMIC HEART DISEASE: COMPARATIVE NONRANDOMIZED STUDY
https://doi.org/10.20996/1819-6446-2010-6-4-513-517
Abstract
Aim. To study effect of diuretic therapy with furosemide and torasemide on heart rate variability (HRV) and frequency of ventriclar rhythm disorders in patients with chronic heart failure (CHF) complicating ischemic heart disease (IHD).
Material and methods. Patients (n=107) with CHF III-IV functional class (NYHA) complicating IHD were examined. The first group of patients received furosemide, 20-60 mg QD (n=52), the second group received torasemide, 5-20 mg QD (n=55). Analysis of heart rhythm disorders and the basic HRV indicators was performed by ECG 10-minute recordings initially and after 10 days of therapy.
Results. Decrease in time and spectral HRV parameters and increase in daily number of ventricular extrasystoles was found in furosemide treated patients. Improvement of HRV parameters and reduction of daily number of ventricular rhythm disorders was found torasemide treated patients.
Conclusion. Torasemide therapy improves an autonomic regulation of heart rhythm and leads to the reduction of ventricular heart rhythm disorders in patients with CHF complicating IHD.
About the Authors
H. H. Shugushev
Medical Faculty of Kabardino-Balkaria State University
Russian Federation
Russian Federation
Chair of Hospital Therapy
Golovko ul. 7 (Municipal Hospital №1), Nalchik, 360000
A. A. Gaeva
Medical Faculty of Kabardino-Balkaria State University
Russian Federation
Russian Federation
Chair of Hospital Therapy
Golovko ul. 7 (Municipal Hospital №1), Nalchik, 360000
References
1. Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т. Хроническая сердечная недостаточность. Избранные лекции по кардиологии. М.: ГЭОТАР-Медиа; 2006.
2. Мухарлямов Н.М., Мареев В.Ю. Лечение хронической сердечной недостаточности. М.: Медицина; 1985.
3. Bratter D.C. Diuretic therapy. N Engl J Med 1998; 339(6): 387-95.
4. Cosín J., Díez J.; TORIC investigators. Torasemide in chronic heart failure results of the TORIC study. Eur J Heart Failure 2002; 4 (4): 507-13.
5. BraterD. Torasemide: pharmacokinetic and clinical efficacy. – EurJHeart Fail 2001; 3 (Suppl G): 19-24.
6. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of European Society of Cardiology and North American Society of Pacing and Electrophysiology. Eur Heart J 1996; 17 (3): 354-381.
7. Yamato M., Sasaki T., Honda K. et al. Effects of torasemide in left ventricular function and neurohumoral factors in patients with chronic heart failure. Circ J 2003; 67(5): 384-390.
8. Müller K., Gamba G., Jaquet F., Hess B. Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV – efficacy and quality of life. Eur J Heart Fail 2003;5(6): 793-801.
9. Tomiyama H., Nakayama T., Watanabe G. et al. Effects of short-acting and longacting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure. Am Heart J 1999; 137 (3): 543-8.
10. Cygankiewicz I., Zareba W., Vazquez R. et al Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%. Am J Cardiol 2009; 103(7):1003-10.
11. Шугушев Х.Х., Гурижева М.В., Василенко В.М. Влияние бронходилататоров на вариабельность ритма сердца у больных хронической обструктивной болезнью легких. Рациональная Фармакотерапия в Кардиологии 2007; 4: 51-54.
Review
For citations:
Shugushev H.H., Gaeva A.A. EFFECT OF FUROSEMIDE AND TORASEMIDE ON HEART RATE VARIABILITY AND VENTRICULAR RHYTHM DISORDERS IN PATIENTS WITH CHRONIC HEART FAILURE COMPLICATING ISCHEMIC HEART DISEASE: COMPARATIVE NONRANDOMIZED STUDY. Rational Pharmacotherapy in Cardiology. 2010;6(4):513-517. (In Russ.) https://doi.org/10.20996/1819-6446-2010-6-4-513-517
Views:
4320
Email this article 